Erectile Dysfunction
📧 Sign up to get email alerts when something new happens for Erectile Dysfunction.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2023-04-24FDA Approved: TADALAFIL — Supplemental Application (Camber Pharmaceuticals, Inc.)
FDA approved a supplemental application for tadalafil filed by Camber Pharmaceuticals, Inc. This action grants an updated approval related t…
-
FDA approval · 2023-04-19FDA Approved: SILDENAFIL — Original Application (Macleods Pharmaceuticals Limited)
FDA approved a generic sildenafil citrate tablet from Macleods Pharmaceuticals Limited as an Original Application (ANDA).
-
EMA approval · 2023-02-24EMA Authorised: Vizarsin (sildenafil) — Krka, d.d., Novo mesto
The EMA authorised Vizarsin (sildenafil) for erectile dysfunction under Krka, d.d., Novo mesto.
-
FDA approval · 2023-01-27FDA Approved: TADALAFIL — Supplemental Application (Solco Healthcare US, LLC)
FDA approved a supplemental application for tadalafil filed by Solco Healthcare US, LLC.
-
FDA approval · 2022-12-23FDA Approved: CAVERJECT IMPULSE — Supplemental Application (Pharmacia & Upjohn Company LLC)
The FDA approved a supplemental application for CAVERJECT IMPULSE (alprostadil) from Pharmacia & Upjohn Company LLC.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2022-12-23FDA Approved: CAVERJECT — Supplemental Application (Pharmacia & Upjohn Company LLC)
FDA approved a supplemental application for CAVERJECT (alprostadil) submitted by Pharmacia & Upjohn Company LLC.
-
FDA approval · 2022-12-23FDA Approved: SILDENAFIL CITRATE — Original Application (Aurobindo Pharma Limited)
FDA approved the original application for sildenafil citrate as a generic product from Aurobindo Pharma Limited.
-
FDA approval · 2022-12-16FDA Approved: TADALAFIL — Supplemental Application (AvKARE)
FDA supplemental approval for tadalafil from AvKARE (ANDA210608).
-
FDA approval · 2022-10-12FDA Approved: ALYQ — Original Application (Teva Pharmaceuticals, Inc.)
The FDA approved ALYQ as Teva's generic tadalafil in an original ANDA approval. The approval covers the same indications as tadalafil, inclu…
-
FDA approval · 2022-09-29FDA Approved: SILDENAFIL CITRATE — Original Application (Zydus Lifesciences Limited)
FDA approved the original ANDA for sildenafil citrate tablets from Zydus Lifesciences Limited, enabling a generic version of sildenafil citr…
-
FDA approval · 2022-08-11FDA Approved: TADALAFIL — Original Application (Solco Healthcare US, LLC)
FDA approved an original ANDA for tadalafil tablets (generic tadalafil) by Solco Healthcare US, LLC. The product is approved for erectile dy…
-
EMA approval · 2022-07-04EMA Authorised: Sildenafil Teva (sildenafil) — Teva B.V.
Authorised erectile dysfunction medicine sildenafil Teva (sildenafil) by Teva B.V. has received approval in the EU.
-
EMA approval · 2022-06-24EMA Authorised: Sildenafil ratiopharm (sildenafil) — Ratiopharm GmbH
EU authorization for Sildenafil ratiopharm for erectile dysfunction; marketing authorization granted to Ratiopharm GmbH.
-
FDA approval · 2022-06-17FDA Approved: TADLIQ — Original Application (CMP Pharma, Inc.)
FDA approved CMP Pharma's TadliQ (tadalafil) under Original Application NDA214522, approving its use for erectile dysfunction and benign pro…
-
FDA approval · 2022-05-27FDA Approved: TADALAFIL — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for Tadalafil submitted by Aurobindo Pharma Limited. This action adds regulatory approval for th…
-
FDA approval · 2022-05-18FDA Approved: TADALAFIL — Supplemental Application (Quallent Pharmaceuticals Health LLC)
The FDA approved a supplemental application for tadalafil from Quallent Pharmaceuticals Health LLC. This action concerns the approval of a g…
-
FDA approval · 2022-04-29FDA Approved: SILDENAFIL CITRATE — Supplemental Application (Ascend Laboratories, LLC)
The FDA approved a supplemental application for sildenafil citrate submitted by Ascend Laboratories, LLC, resulting in approval of a generic…
-
FDA approval · 2022-03-23FDA Approved: SILDENAFIL — Original Application (Lupin Pharmaceuticals, Inc.)
FDA approves Lupin Pharmaceuticals' original application for sildenafil, a generic version of the erectile dysfunction treatment.
-
FDA approval · 2022-02-08FDA Approved: SILDENAFIL CITRATE — Original Application (Novadoz Pharmaceuticals LLC)
The FDA approved Sildenafil Citrate (generic) from Novadoz Pharmaceuticals LLC under an Original Application (ANDA), enabling market entry f…
-
FDA approval · 2021-11-04FDA Approved: TADALAFIL — Original Application (Burel Pharmaceuticals, LLC)
The FDA approved a generic tadalafil product under an original ANDA for Burel Pharmaceuticals, LLC.
-
FDA approval · 2021-05-11FDA Approved: SILDENAFIL — Original Application (Camber Pharmaceuticals, Inc.)
FDA approves Camber Pharmaceuticals' original ANDA for a sildenafil powder product, a generic version of sildenafil.
-
FDA approval · 2021-04-29FDA Approved: SILDENAFIL — Original Application (Virtus Pharmaceuticals, LLC)
The FDA approved Virtus Pharmaceuticals' original ANDA for sildenafil, enabling a generic version of the erectile dysfunction drug.
-
FDA approval · 2021-03-17FDA Approved: TADALAFIL — Supplemental Application (Cipla USA Inc.)
The FDA approved a supplemental application for tadalafil from Cipla USA Inc. under ANDA210255, expanding the approved generic product for a…
-
FDA approval · 2021-02-11FDA Approved: TADALAFIL — Supplemental Application (Macleods Pharmaceuticals Limited)
The FDA approved a supplemental application for tadalafil from Macleods Pharmaceuticals Limited.
-
FDA approval · 2021-01-07FDA Approved: TADALAFIL — Supplemental Application (HEC Pharm USA Inc.)
The FDA approved a supplemental application for tadalafil from HEC Pharm USA Inc., indicating approval of an additional generic tadalafil pr…